• Thursday,September 19,2024
ic-yoga.cz
X

The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

$ 14.50

4.5 (796) In stock

Share

We launched Calibrate with the mission to change the way the world treats weight. In our first year, we have proven that Calibrate works. Our combination of doctor-prescribed, FDA-approved GLP-1…

LGC E102 - Isabelle Kenyon Changing the way the world treats weight by Let's Grab Coffee Podcast ☕

The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

Ep439: Isabelle Kenyon, Founder & CEO, Calibrate, Ep439: Isabelle Kenyon

Exclusive: Telehealth Startup Calibrate Notches A $100 Million Series B From Founders Fund And Tiger Global

Startups Chasing the $100 Billion Market for Weight-Loss Drugs

In NYC, the Future of Healthtech Is Female

Kristen Coletto, Aetion, on using Real World Evidence to accelerate drug discovery and commercialization by The Pulse by Wharton Digital Health

August 2021 – The Health Care Blog

How we're building the team and the tools to fight biology with biology, by Isabelle Kenyon

2021 Review of Funding for Female Founders, by Female Founders Fund

Isabelle Kenyon, CEO & Founder of Calibrate, on setting a new standard of care for managing metabolic health, by Cate Stanton, The Pulse by Wharton Digital Health

launches Clinic + Calibrate CEO Isabelle Kenyon on metabolic health

Weight-Loss Startup Calibrate Sells to Madryn Asset Management

Weight-Loss Startup Calibrate Faces Mountain of Patient Complaints and Refunds

These Are the Healthcare Startups Doing Layoffs in 2023